Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30412577 | 1.00 | CA1 (0.43) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL135551 | 1.00 | CA1 (0.43) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL28167378 | 0.96 | CA1 (0.42) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL11474625 | 0.96 | CA1 (0.42) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL28167323 | 0.96 | CA1 (0.42) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL16191148 | 0.93 | CA1 (0.46) | CA1CA2CA4SHBGNOS3 | |
| SCHEMBL2688489 | 0.92 | — | — | |
| SCHEMBL11689682 | 0.92 | — | — | |
| SCHEMBL11687417 | 0.92 | — | — | |
| SCHEMBL16191185 | 0.90 | CA1 (0.39) | CA1CA2CA4SHBGNOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840610-B2 | Compositions and methods for the degradation of waste polypropylene | NOVOLOOP, INC. (US) | 2023-12-12 | — | — | US | claimed |
| CN-115210310-A | Composition and method for waste polypropylene degradation | 诺弗洛普有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115210310-A | Composition and method for waste polypropylene degradation | 诺弗洛普有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-10906033-B2 | Synthesis and application of chiral substituted polyvinylpyrrolidinones | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200306737-A1 | SYNTHESIS AND APPLICATION OF CHIRAL SUBSTITUTED POLYVINYLPYRROLIDINONES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2020-10-01 | — | — | US | disclosed |
| US-9862657-B2 | Methods for selectively hydrogenating substituted arenes with supported organometallic catalysts | UOP LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-20160159709-A1 | METHODS FOR SELECTIVELY HYDROGENATING SUBSTITUTED ARENES WITH SUPPORTED ORGANOMETALLIC CATALYSTS | NORTHWESTERN UNIVERSITY | 2016-06-09 | — | — | US | disclosed |
| CN-101504399-B | Qualitative and quantitative analysis method for hydrogenated tail-oil long and straight side chain cycloparaffin and alkylbenzene | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2011-12-07 | — | — | CN | disclosed |
| CN-101504399-A | Qualitative and quantitative analysis method for hydrogenated tail-oil long and straight side chain cycloparaffin and alkylbenzene | UNIV BEIJING CHEMICAL (CN) | 2009-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159709-A1 | METHODS FOR SELECTIVELY HYDROGENATING SUBSTITUTED ARENES WITH SUPPORTED ORGANOMETALLIC CATALYSTS | HPSE, TST, STS | CA1 124/4885CA2 229/4885CA4 168/4885 |
| US-20200306737-A1 | SYNTHESIS AND APPLICATION OF CHIRAL SUBSTITUTED POLYVINYLPYRROLIDINONES | POLRMT, CNBP, DHPS | CA1 2746/4885CA2 3039/4885CA4 2228/4885 |
| US-10906033-B2 | Synthesis and application of chiral substituted polyvinylpyrrolidinones | POLRMT, CNBP, DHPS | CA1 2746/4885CA2 3039/4885CA4 2228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.